24/7 Patient Assistance: 760-405-8205

Omer Kucuk, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Omer Kucuk is a medical oncologist from Atlanta, Georgia and he works at several hospitals in the area, such as Emory University Hospital and Emory University Hospital Midtown. He got his diploma from Hacettepe University Faculty of Medicine and did his residency in Internal Medicine at Saint Francis Hospital. Dr. Omer Kucuk did three fellowships in Medical Oncology at McGaw Medical Center of Northwestern University and Hematology and Medical Oncology at Saint Francis Hospital. The doctor is certified in Hematology, Internal Medicine, Medical Oncology and has an experience of more than 20 years.


  • Education & Training

    dept_icon

    Hacettepe University Faculty of Medicine

    Medical School

    dept_icon

    Saint Francis Hospital

    Residency

    dept_icon

    Saint Francis Hospital

    Fellowship

    dept_icon

    McGaw Medical Center of Northwestern University

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Hematology

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Emory University Hospital

    Languages: English/Spanish

    (404) 712–2000

    1364 Clifton Road NE

    Atlanta, Georgia 30322-1102

    Read More

    Emory University Hospital Midtown

    Languages: English/Spanish

    (404) 686–4411

    550 Peachtree Street NE

    Atlanta, Georgia 30308-2247

    Read More
  • Publications & Memberships

    Dr. Omer Kucuk has contributed to 3 publications.

    Effects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancer.

    Bilir, B.,Sharma, N. V.,Lee, J.,Hammarstrom, B.,Svindland, A.,Kucuk, O.,Moreno, C. S.; Int. J. Oncol.. 2017 Jun 01.

    See more >>

    The role of adjuvant radiotherapy in pathologically lymph node-positive prostate cancer.

    Jegadeesh N, Liu Y, Zhang C, Zhong J, Cassidy RJ, Gillespie T, Kucuk O, Rossi P, Master VA, Alemozaffar M, Jani AB; Cancer. 2016-11-08.

    See more >>

    Impact of 18F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial.

    Jani A, Schreibmann E, Rossi PJ, Shelton JW, Godette K, Nieh P, Master VA, Kucuk O, Goodman M, Halkar R, Cooper S, Chen Z, Schuster DM; J. Nucl. Med.. 2016-09-08.

    See more >>